• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫酸镁与促肾上腺皮质激素联合治疗一线治疗失败的婴儿痉挛症的疗效

Response to magnesium sulfate and adrenocorticotropic hormone combination therapy for infantile spasms with failed first-line treatments.

作者信息

Wang Qiuhong, He Wen, Wang Yangyang, Liu Liying, Zhang Mengna, Yang Xiaoyan, Zou Liping

机构信息

Department of Pediatrics Chinese PLA General Hospital The First Medical Center of Chinese PLA General Hospital Beijing China.

Department of Pediatrics, Beijing Institute for Brain Disorders, Center for Brain Disorders Research Capital Medical University Beijing China.

出版信息

Pediatr Investig. 2023 Mar 9;7(1):29-35. doi: 10.1002/ped4.12368. eCollection 2023 Mar.

DOI:10.1002/ped4.12368
PMID:36967744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10030695/
Abstract

IMPORTANCE

Infantile spasm (IS) is a kind of refractory epilepsy. The first-line treatments for IS are adrenocorticotropic hormone (ACTH), oral corticosteroids, and vigabatrin.

OBJECTIVE

This study aimed to evaluate the efficacy of magnesium sulfate and ACTH (MgSO+ACTH) combination therapy in patients with IS who failed first-line treatments.

METHODS

In this retrospective study, the clinical data of patients with IS who failed first-line treatments were collected in the Chinese PLA General Hospital. Patients received MgSO+ACTH combination therapy after first-line treatments failed. The course of treatments was 2 weeks. The therapeutic dose of ACTH and MgSO was 2.5 U·kg·d and 0.25 g·kg·d, respectively.

RESULTS

A total of 229 patients with IS who failed the first-line treatments were collected. At the end of the MgSO+ACTH combination treatment, the seizure-free rate was 48.5% (111/229), and the resolution of hypsarrhythmia on electroencephalogram (EEG) was 72.1% (165/229). About 21.4% (49/229) of patients showed side effects, including infectious diseases, hypokalemia, and diarrhea.

INTERPRETATION

For patients with IS who failed first-line treatments, in terms of the seizure-free rate and resolution of hypsarrhythmia on EEG, MgSO+ACTH combination therapy can be considered.

摘要

重要性

婴儿痉挛症(IS)是一种难治性癫痫。IS的一线治疗方法是促肾上腺皮质激素(ACTH)、口服皮质类固醇和氨己烯酸。

目的

本研究旨在评估硫酸镁与ACTH(MgSO+ACTH)联合治疗对一线治疗失败的IS患者的疗效。

方法

在这项回顾性研究中,收集了中国人民解放军总医院一线治疗失败的IS患者的临床资料。患者在一线治疗失败后接受MgSO+ACTH联合治疗。疗程为2周。ACTH和MgSO的治疗剂量分别为2.5 U·kg·d和0.25 g·kg·d。

结果

共收集到229例一线治疗失败的IS患者。在MgSO+ACTH联合治疗结束时,无癫痫发作率为48.5%(111/229),脑电图(EEG)高峰失律消失率为72.1%(165/229)。约21.4%(49/229)的患者出现副作用,包括传染病、低钾血症和腹泻。

解读

对于一线治疗失败的IS患者,就无癫痫发作率和EEG高峰失律消失率而言,可考虑MgSO+ACTH联合治疗。

相似文献

1
Response to magnesium sulfate and adrenocorticotropic hormone combination therapy for infantile spasms with failed first-line treatments.硫酸镁与促肾上腺皮质激素联合治疗一线治疗失败的婴儿痉挛症的疗效
Pediatr Investig. 2023 Mar 9;7(1):29-35. doi: 10.1002/ped4.12368. eCollection 2023 Mar.
2
Adrenocorticotropic hormone combined with magnesium sulfate therapy for infantile epileptic spasms syndrome: a real-world study.促肾上腺皮质激素联合硫酸镁治疗婴儿癫痫性痉挛综合征:一项真实世界研究。
World J Pediatr. 2024 Aug;20(8):834-847. doi: 10.1007/s12519-023-00771-1. Epub 2023 Dec 9.
3
Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: a 24-week, randomized, open-label, follow-up study in China.在中国进行的为期 24 周的随机、开放标签、随访研究:3 周 ACTH+硫酸镁联合治疗与 ACTH 单药治疗婴儿痉挛的疗效比较。
Clin Ther. 2010 Apr;32(4):692-700. doi: 10.1016/j.clinthera.2010.04.008.
4
Adrenocorticotropic hormone for the treatment of West Syndrome in children.促肾上腺皮质激素治疗儿童 West 综合征。
Ann Pharmacother. 2013 May;47(5):744-54. doi: 10.1345/aph.1R535. Epub 2013 Apr 19.
5
Treatment of children with infantile spasms: A network meta-analysis.婴儿痉挛症患儿的治疗:网状荟萃分析。
Dev Med Child Neurol. 2022 Nov;64(11):1330-1343. doi: 10.1111/dmcn.15330. Epub 2022 Jun 29.
6
Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia.促肾上腺皮质激素单药治疗伴有脑室周围白质软化症的婴儿癫痫性痉挛综合征的长期分析。
Seizure. 2023 Jul;109:40-44. doi: 10.1016/j.seizure.2023.05.012. Epub 2023 May 16.
7
The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.高峰失律对婴儿痉挛症治疗反应的影响:来自国家婴儿痉挛症联盟的观察性队列研究
Epilepsia. 2017 Dec;58(12):2098-2103. doi: 10.1111/epi.13937. Epub 2017 Nov 3.
8
[Factors influencing the efficacy of initial adrenocorticotropic hormone therapy for infantile epileptic spasms syndrome].[影响婴儿痉挛症综合征初始促肾上腺皮质激素治疗疗效的因素]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jan 15;25(1):60-66. doi: 10.7499/j.issn.1008-8830.2207096.
9
Long-Term Outcome of Adrenocorticotropic Hormone Therapy in Children With New-Onset Infantile Spasms.新诊断婴儿痉挛症患儿促肾上腺皮质激素治疗的长期结局。
Pediatr Neurol. 2023 Jun;143:100-105. doi: 10.1016/j.pediatrneurol.2023.02.009. Epub 2023 Feb 24.
10
Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice.婴儿痉挛症的治疗方法:临床实践中的当前考虑因素和不断发展的策略。
Neurol Sci. 2024 Feb;45(2):507-514. doi: 10.1007/s10072-023-07078-z. Epub 2023 Sep 22.

本文引用的文献

1
Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.难治性惊厥性癫痫持续状态的治疗:美国癫痫协会治疗委员会的全面综述
Epilepsy Curr. 2020 Sep;20(5):245-264. doi: 10.1177/1535759720928269. Epub 2020 Aug 21.
2
Effect of lifetime antiepileptic drug treatment history on efficacy and tolerability of adjunctive brivaracetam in adults with focal seizures: Post-hoc analysis of a randomized, placebo-controlled trial.毕生抗癫痫药物治疗史对附加用左乙拉西坦治疗局灶性癫痫发作成人的疗效和耐受性的影响:一项随机、安慰剂对照试验的事后分析。
Epilepsy Res. 2020 Nov;167:106369. doi: 10.1016/j.eplepsyres.2020.106369. Epub 2020 May 25.
3
West Syndrome: A Review and Guide for Paediatricians.
婴儿痉挛症:儿科医生的综述与指导。
Clin Drug Investig. 2018 Feb;38(2):113-124. doi: 10.1007/s40261-017-0595-z.
4
Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.激素治疗与激素加氨己烯酸治疗婴儿痉挛症的安全性和有效性(ICISS):一项随机、多中心、开放标签试验。
Lancet Neurol. 2017 Jan;16(1):33-42. doi: 10.1016/S1474-4422(16)30294-0. Epub 2016 Nov 10.
5
Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.多中心前瞻性婴儿痉挛症队列中初始治疗失败后对二次治疗的反应
Epilepsia. 2016 Nov;57(11):1834-1842. doi: 10.1111/epi.13557. Epub 2016 Sep 12.
6
Response to treatment in a prospective national infantile spasms cohort.一项全国性前瞻性婴儿痉挛症队列研究中的治疗反应
Ann Neurol. 2016 Mar;79(3):475-84. doi: 10.1002/ana.24594. Epub 2016 Feb 13.
7
Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis.基于基线抗癫痫药物数量及疗效的基线预测因素的辅助用吡仑帕奈的疗效和耐受性:一项III期事后分析。
Epilepsy Res. 2016 Jan;119:34-40. doi: 10.1016/j.eplepsyres.2015.11.014. Epub 2015 Dec 1.
8
Infantile spasms syndrome, West syndrome and related phenotypes: what we know in 2013.婴儿痉挛症、韦斯特综合征及相关表型:2013年我们所了解的情况
Brain Dev. 2014 Oct;36(9):739-51. doi: 10.1016/j.braindev.2013.10.008. Epub 2013 Nov 20.
9
Adrenocorticotropic hormone for the treatment of West Syndrome in children.促肾上腺皮质激素治疗儿童 West 综合征。
Ann Pharmacother. 2013 May;47(5):744-54. doi: 10.1345/aph.1R535. Epub 2013 Apr 19.
10
Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.循证指南更新:婴儿痉挛的治疗。美国神经病学学会指南发展分委会和儿童神经病学会实践委员会的报告。
Neurology. 2012 Jun 12;78(24):1974-80. doi: 10.1212/WNL.0b013e318259e2cf.